IBM vs KZR · P/E 25, rev $17.16B vs $53.9M cap
International Business Machines (IBM) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. KZR currently screens at market cap $53.9M.
Not investment advice. Open the IBM and KZR stock pages for the full models.
Not investment advice.